A rare case of Watson syndrome.
Sabzi F, Heydari A, Heidari Moghaddam R, Rouzbahani M, Asadmobini A.
Folia Med (Plovdiv). 2022 Aug 31;64(4):672-675. doi: 10.3897/folmed.64.e63559.
Health Supervision for Children With Neurofibromatosis Type 1.
Miller DT, Freedenberg D, Schorry E, Ullrich NJ, Viskochil D, Korf BR; COUNCIL ON GENETICS; AMERICAN COLLEGE OF MEDICAL GENETICS AND GENOMICS.
Pediatrics. 2019 May;143(5):e20190660. doi: 10.1542/peds.2019-0660.
Neurofibromatosis type 1.
Cimino PJ, Gutmann DH.
Handb Clin Neurol. 2018;148:799-811. doi: 10.1016/B978-0-444-64076-5.00051-X.
Neurofibromatosis type 1 (NF1): diagnosis and management.
Ferner RE, Gutmann DH.
Handb Clin Neurol. 2013;115:939-55. doi: 10.1016/B978-0-444-52902-2.00053-9.
Watson syndrome: is it a subtype of type 1 neurofibromatosis?
Allanson JE, Upadhyaya M, Watson GH, Partington M, MacKenzie A, Lahey D, MacLeod H, Sarfarazi M, Broadhead W, Harper PS, et al.
J Med Genet. 1991 Nov;28(11):752-6. doi: 10.1136/jmg.28.11.752.
The management of neurofibromatosis type 1 (NF1) in children and adolescents.
Kerashvili N, Gutmann DH.
Expert Rev Neurother. 2024 Apr;24(4):409-420. doi: 10.1080/14737175.2024.2324117. Epub 2024 Feb 27.
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.
Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A.
J Med Genet. 2007 Feb;44(2):81-8. doi: 10.1136/jmg.2006.045906. Epub 2006 Nov 14.
Neurofibromatosis type 1 system-based manifestations and treatments: a review.
Saleh M, Dib A, Beaini S, Saad C, Faraj S, El Joueid Y, Kotob Y, Saoudi L, Emmanuel N.
Neurol Sci. 2023 Jun;44(6):1931-1947. doi: 10.1007/s10072-023-06680-5. Epub 2023 Feb 24.
Watson's syndrome.
Kumar BB.
Am J Dis Child. 1972 Jun;123(6):612. doi: 10.1001/archpedi.1972.02110120136027.
Schwannomatosis.
Hans VH, Surov A, Kornhuber M, Behrmann C.
Neurology. 2009 Mar 31;72(13):1188; author reply 1188-9. doi: 10.1212/01.wnl.0000339391.48966.ab.
